(Q40876344)

English

Establishment and characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant cell lines

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

Establishment and characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant cell lines (English)

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

author name string

Y Aoyagi

1

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

T Kobunai

2

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

T Utsugi

3

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

K Wierzba

4

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

Y Yamada

5

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

publication date

1 May 2000

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

91

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

5

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

543-550

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Multidrug resistance mediated by the multidrug resistance protein (MRP) gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Immunohistochemical study of DNA topoisomerase II in human gastric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

DNA topoisomerases: essential enzymes and lethal targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Characterization of an etoposide-resistant human ovarian cancer cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Characterization of an etoposide-resistant human small-cell lung cancer cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

DNA topoisomerase-targeting antitumor agents and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

3 July 2018

In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerases I and II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

19 August 2018

Eukaryotic DNA topoisomerase II beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

19 August 2018

Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

19 August 2018

Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926383

19 August 2018

Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/10835500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10835500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10835500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10835500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A carbamate analogue of amsacrine with activity against non-cycling cells stimulates topoisomerase II cleavage at DNA sites distinct from those of amsacrine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10835500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.2000.TB00979.X

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 July 2018

http://europepmc.org/abstract/PMC/5926383

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40876344&oldid=1909414583"